Next, pancreatic cancer cells (PANC-1 and MIA PaCa-2) were treated with different concentrations of alizarin (10 and 20 μM), and alizarin inhibited the phosphorylation of TAK1 and IKBα in a dose-dependent manner (Figure 4B). The gene discussed is NFKBIA; the disease is pancreatic neoplasm.